Clinical trial outcomes for SLE: what we have and what we need Laurent Arnaud, Ioannis Parodis, Hervé Devilliers, Francois Chasset
15 February 2024
Evaluation of RNase therapy in systemic lupus erythematosus: a randomised phase 2a clinical trial of RSLV-132 Daniel J Burge, Victoria P Werth, Susan A Boackle, James Posada
7 February 2024
Systemic lupus in the era of machine learning medicine Kevin Zhan, Katherine A Buhler, Irene Y Chen, Marvin J Fritzler, May Y Choi
4 March 2024
Anifrolumab in lupus nephritis: results from second-year extension of a randomised phase II trial David Jayne, Brad Rovin, Eduardo Mysler, Richard Furie, Frédéric Houssiau, Teodora Trasieva, Jacob Knagenhjelm, Erik Schwetje, Weifeng Tang, Raj Tummala, Catharina Lindholm
22 August 2023
Fragility of randomised controlled trials for systemic lupus erythematosus and lupus nephritis therapies Gabriel Figueroa-Parra, Michael S Putman, Cynthia S Crowson, Alí Duarte-García
10 January 2024
Rituximab as an effective add-on maintenance therapy for disease activities in childhood-onset systemic lupus erythematosus Ting-Wei Lin, Yu-Tsan Lin, Ya-Chiao Hu, Hsin-Hui Yu, Bor-Luen Chiang
19 January 2024
Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks Binod Neupane, Pragya Shukla, Mahmoud Slim, Amber Martin, Michelle Petri, George K Bertsias, Alfred H J Kim, Antonis Fanouriakis, Roger A Levy, Deven Chauhan, Nick Ballew
5 May 2023
Circulating neutrophil extracellular trap remnants as a biomarker to predict outcomes in lupus nephritis Laura Patricia Whittall-Garcia, Farnoosh Naderinabi, Dafna D Gladman, Murray Urowitz, Zahi Touma, Ana Konvalinka, Joan Wither
4 January 2024
Therapeutic drug monitoring of mycophenolic acid and clinical outcomes of lupus nephritis: a systematic review and meta-analysis Thunyatorn Wuttiputhanun, Nuanjanthip Naiyarakseree, Suwasin Udomkarnjananun, Wonngarm Kittanamongkolchai, Leelahavanichkul Asada, Pajaree Chariyavilaskul, Natavudh Townamchai, Yingyos Avihingsanon
17 January 2024
Prevalence of coeliac disease in patients with systemic lupus erythematosus: a systematic review and meta-analysis Adonis Sotoodeh, Madeleine Nguyen Hoang, Karin Hellgren, Anders Forss
13 February 2024
Clinical implications of discordance between anti-dsDNA antibodies by multiplex flow immunoassay and Crithidia luciliae assay in a multiethnic racial cohort of patients with SLE Devyn Zaminski, Amit Saxena, Peter Izmirly, Jill P Buyon, H Michael Belmont
14 November 2023
Efficacy and safety of telitacicept in patients with systemic lupus erythematosus: a multicentre, retrospective, real-world study Hui-Zhi Jin, Yu-jing Li, Xin Wang, Zhijun Li, Bin Ma, Lin Niu, Peng Wang, Hai-feng Pan, Si-dong Li, Wei Bao, Guosheng Wang, Xiao-mei Li, Zhu Chen
24 November 2023
Development and psychometric evaluation of a physician global assessment for type 2 systemic lupus erythematosus symptoms Megan E B Clowse, Jennifer L Rogers, Theresa Coles, David S Pisetsky, Lisa G Criscione-Schreiber, Dana Burshell, Jayanth Doss, Rebecca E Sadun, Kai Sun, Mithu Maheswaranathan, Amanda M Eudy
17 December 2023
Therapy with direct oral anticoagulants for secondary prevention of thromboembolic events in the antiphospholipid syndrome: a systematic review and meta-analysis of randomised trials Josefine B H Adelhelm, Robin Christensen, Gustavo G M Balbi, Anne Voss
29 October 2023
Mezagitamab in systemic lupus erythematosus: clinical and mechanistic findings of CD38 inhibition in an autoimmune disease Scott R P McDonnell, Van Anh Nguyen, Noah M Walton, Carsten Merkwirth, Feng Hong, Deborah Berg, Elena Tomaselli Muensterman, Richard A Furie
7 March 2024
High-density lipoprotein cholesterol subfraction HDL2 is associated with improved endothelial function in systemic lupus erythematosus Ainsley Ryan Yan Bin Lee, Chun En Yau, Cheryl Kai Ting Chua, Wan Ling Cheng, Avery Joy Li Chia, Shi Yin Wong, Nien Yee Kow, Lingli Gong, Bernett Teck Kwong Lee, Lieng Hsi Ling, Anselm Mak, Tze Ping Loh, Sen Hee Tay
22 January 2024
Expert consensus achieved on a working core outcome set for cutaneous lupus erythematosus research in survey following the 5th International Conference on Cutaneous Lupus Erythematosus (ICCLE) Arianna J Zhang, Lourdes M Perez-Chada, Victoria P Werth, Joseph F Merola
26 February 2024
Steroid-sparing effect of belimumab: results from a retrospective observational study of real-world data Karen Worley, Scott Milligan, Bernard Rubin
22 December 2023
Add-on sirolimus for the treatment of mild or moderate systemic lupus erythematosus via T lymphocyte subsets balance Meng Ding, Lu Jin, Jinwen Zhao, Lin Yang, Shaoxin Cui, Xiaoping Wang, Jingjing He, Fei Chang, Min Shi, Jun Ma, Shuran Song, Hongtao Jin, Aijing Liu
13 February 2024
Risk factors of first thrombosis in obstetric antiphospholipid syndrome Liang Luo, Qingmeng Cai, Xiangjun Liu, Yuke Hou, Chun Li
3 January 2024